| Literature DB >> 32702215 |
Minjee Jung1, Seung Yeon Baik1, Yourim Kim1, Sungkean Kim1, Dongil Min1, Jeong-Youn Kim1, Seunghee Won2, Seung-Hwan Lee1,3.
Abstract
OBJECTIVE: While impaired facial expression recognition has been closely associated with reduced temporal lobe volume in patients with schizophrenia, this study aimed at examining whether empathy and social attribution affect such a relationship.Entities:
Keywords: Empathy; Facial emotion recognition task.; Schizophrenia; Social attribution; Social cognitive ability; Temporal lobe
Year: 2020 PMID: 32702215 PMCID: PMC7383013 DOI: 10.9758/cpn.2020.18.3.362
Source DB: PubMed Journal: Clin Psychopharmacol Neurosci ISSN: 1738-1088 Impact factor: 2.582
Participants’ demographic information (n = 86)
| Variable | Patients with schizophrenia (n = 43) | Healthy controls (n = 43) |
|
|---|---|---|---|
| Demographics | |||
| Sex | |||
| Male | 16 (37.2) | 20 (46.5) | 0.382 |
| Female | 27 (62.8) | 23 (53.5) | |
| Age (yr) | 43.42 ± 10.83 | 39.93 ± 13.21 | 0.184 |
| Education (yr) | 13.37 ± 2.80 | 14.58 ± 3.67 | 0.089 |
| Pre-morbid IQ/IQ | 99.36 ± 10.32 | 107.97 ± 8.58 | < 0.001 |
| DOI (yr) | 12.87 ± 8.34 | - | |
| CPZeq (mg) | 470.50 ± 607.15 | - | |
| Brain volume (mm3) | |||
| TIV | 1,542.59 ± 156.45 | 1,564.45 ± 151.74 | 0.513 |
| LHV | 2.99 ± 0.42 | 3.26 ± 0.42 | 0.004 |
| RHV | 3.32 ± 0.59 | 3.62 ± 0.40 | 0.008 |
| LAV | 0.88 ± 0.11 | 0.96 ± 0.10 | < 0.001 |
| RAV | 0.85 ± 0.14 | 0.94 ± 0.10 | 0.001 |
| LFV | 7.86 ± 1.11 | 8.40 ± 1.21 | 0.036 |
| RFV | 7.59 ± 1.25 | 8.26 ± 1.16 | 0.008 |
| LSTV | 5.93 ± 0.90 | 6.38 ± 0.95 | 0.026 |
| RSTV | 6.33 ± 0.92 | 6.83 ± 1.01 | 0.019 |
| LMTV | 13.54 ± 1.96 | 14.90 ± 2.06 | 0.002 |
| RMTV | 13.57 ± 2.05 | 15.04 ± 2.00 | 0.001 |
| FERT and social cognitive scales | |||
| BES | 66.78 ± 8.67 | 74.95 ± 7.99 | < 0.001 |
| SAT-MC | 8.81 ± 4.79 | 14.50 ± 3.69 | < 0.001 |
| FERT-ACC (%) | 0.52 ± 0.18 | 0.73 ± 0.12 | < 0.001 |
| FERT-RT (ms) | 2,123.04 ± 351.80 | 1,740.74 ± 267.04 | < 0.001 |
Values are presented as number (%) or mean ± standard deviation.
DOI, duration of illness; CPZeq, chlorpromazine equivalent; TIV, total intracranial volume; LHV, left hippocampus volume; RHV, right hippocampus volume; LAV, left amygdala volume; RAV, right amygdala volume; LFV, left fusiform gyrus volume; RFV, right fusiform gyrus volume; LSTV, left superior temporal gyrus volume; RSTV, right superior temporal gyrus volume; LMTV, left middle temporal gyrus volume; RMTV, right middle temporal gyrus volume; BES, basic empathy scale; SAT-MC, social attribution task-multiple choice; FERT-ACC, facial expression recognition task-accuracy; FERT-RT, facial expression recognition task-response time.
Fig. 1Regions of interest for examination of the temporal lobe volume and FERT-ACC in patients with schizophrenia shown in (A) left view, (B) right view, (C) bottom view, and (D) left hemisphere. FERT-ACC, facial expression recognition task-accuracy; RFV, right fusiform gyrus volume; RMTV, right middle temporal gyrus volume; LAV, left amygdala volume; LFV, left fusiform gyrus volume; LSTV, left superior temporal gyrus volume; RSTV, right superior temporal gyrus volume; LMTV, left middle temporal gyrus volume.
Fig. 2BES and SAT-MC as moderators of the relationship between the temporal lobe volume and FERT-ACC in patients with schizophrenia. LAV, left amygdala volume; LFV, left fusiform gyrus volume; RFV, right fusiform gyrus volume; LSTV, left superior temporal gyrus volume; RSTV, right superior temporal gyrus volume; LMTV, left middle temporal gyrus volume; RMTV, right middle temporal gyrus volume; BES, basic empathy scale; SAT-MC, social attribution task-multiple choice; FERT-ACC, facial expression recognition task-accuracy.
Regression analysis examining moderation effects between temporal lobe volume and social cognitive abilities on FERT-ACC in schizophrenia (n = 43)
| Predictor | Left | Right | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| B | SE |
|
| R2 | B | SE |
|
| R2 | |
| Amygdala volume | ||||||||||
| Constant | −3.65 | 1.27 | −2.88 | 0.007 | 0.70 | −1.91 | 1.29 | −1.48 | 0.148 | 0.61 |
| Sex | 0.11 | 0.05 | 2.26 | 0.031 | 0.068 | 0.05 | 1.29 | 0.207 | ||
| Age | −0.00 | 0.00 | −1.91 | 0.065 | −0.01 | 0.00 | −3.21 | 0.003 | ||
| Education | 0.01 | 0.01 | 0.76 | 0.456 | 0.01 | 0.00 | 0.87 | 0.392 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 2.83 | 0.008 | 0.01 | 0.00 | 2.58 | 0.015 | ||
| DOI | −0.00 | 0.00 | −0.78 | 0.441 | 0.00 | 0.00 | 0.07 | 0.944 | ||
| CPZeq | −0.00 | 0.00 | −1.81 | 0.080 | −0.00 | 0.00 | −1.83 | 0.076 | ||
| TIV | 0.00 | 0.00 | 0.35 | 0.729 | 0.00 | 0.00 | 0.59 | 0.556 | ||
| LAV | 3.83 | 1.34 | 2.85 | 0.008 | ||||||
| RAV | 1.76 | 1.36 | 1.30 | 0.205 | ||||||
| BES | 0.05 | 0.02 | 2.48 | 0.019 | 0.03 | 0.02 | 1.34 | 0.189 | ||
| LAV*BES | −0.05 | 0.02 | −2.42 | 0.022 | 0.76 | |||||
| RAV*BES | −0.03 | 0.00 | −2.27 | 0.030 | 0.63 | |||||
| Fusiform gyrus volume | ||||||||||
| Constant | −3.27 | 1.40 | −2.33 | 0.026 | 0.77 | −3.14 | 1.24 | −2.52 | 0.017 | 0.67 |
| Sex | 0.059 | 0.05 | 1.18 | 0.245 | 0.06 | 0.05 | 1.15 | 0.258 | ||
| Age | −0.01 | 0.00 | −2.87 | 0.007 | −0.01 | 0.00 | −3.57 | 0.001 | ||
| Education | 0.01 | 0.01 | 1.51 | 0.140 | 0.01 | 0.01 | 1.40 | 0.173 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 2.28 | 0.029 | 0.00 | 0.00 | 2.84 | 0.008 | ||
| DOI | 0.00 | 0.00 | 0.16 | 0.875 | 0.00 | 0.00 | 0.19 | 0.852 | ||
| CPZeq | −0.00 | 0.00 | −2.13 | 0.041 | −0.00 | 0.00 | −2.02 | 0.052 | ||
| TIV | 0.00 | 0.00 | 0.29 | 0.773 | 0.00 | 0.00 | 0.74 | 0.464 | ||
| LFV | 0.37 | 0.17 | 2.19 | 0.036 | ||||||
| RFV | 0.33 | 0.15 | 2.25 | 0.031 | ||||||
| BES | 0.05 | 0.02 | 2.23 | 0.033 | 0.05 | 0.02 | 2.44 | 0.021 | ||
| LFV*BES | −0.01 | 0.00 | −2.08 | 0.045 | 0.81 | |||||
| RFV*BES | −0.01 | 0.00 | −2.27 | 0.030 | 0.74 | |||||
| Superior temporal gyrus volume | ||||||||||
| Constant | −4.25 | 1.46 | −2.91 | 0.007 | 0.67 | −3.94 | 1.55 | −2.54 | 0.016 | 0.66 |
| Sex | 0.08 | 0.05 | 1.71 | 0.100 | 0.082 | 0.05 | 1.67 | 0.104 | ||
| Age | −0.01 | 0.00 | −2.69 | 0.011 | −0.01 | 0.00 | −2.72 | 0.011 | ||
| Education | 0.01 | 0.01 | 1.65 | 0.110 | 0.01 | 0.01 | 1.57 | 0.126 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 2.45 | 0.020 | 0.01 | 0.00 | 2.46 | 0.020 | ||
| DOI | −0.00 | 0.00 | −0.21 | 0.835 | −0.00 | 0.00 | −0.40 | 0.694 | ||
| CPZeq | 0.00 | 0.00 | −1.52 | 0.138 | 0.00 | 0.00 | −1.50 | 0.143 | ||
| TIV | 0.00 | 0.00 | −0.11 | 0.913 | 0.00 | 0.00 | −0.23 | 0.819 | ||
| LSTV | 0.66 | 0.24 | 2.79 | 0.009 | ||||||
| RSTV | 0.58 | 0.23 | 2.50 | 0.018 | ||||||
| BES | 0.06 | 0.02 | 2.80 | 0.009 | 0.05 | 0.02 | 2.42 | 0.021 | ||
| LSTV*BES | −0.01 | 0.00 | −2.67 | 0.012 | 0.74 | |||||
| RSTV*BES | −0.01 | 0.00 | −2.32 | 0.027 | 0.72 | |||||
| Middle temporal gyrus volume | ||||||||||
| Constant | −2.92 | 1.27 | −2.30 | 0.028 | 0.64 | −3.50 | 1.28 | −2.74 | 0.010 | 0.65 |
| Sex | 0.07 | 0.05 | 1.46 | 0.153 | 0.08 | 0.05 | 1.53 | 0.136 | ||
| Age | −0.01 | 0.00 | −2.52 | 0.017 | −0.01 | 0.00 | −2.74 | 0.010 | ||
| Education | 0.01 | 0.01 | 1.39 | 0.173 | 0.01 | 0.01 | 1.27 | 0.215 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 2.56 | 0.015 | 0.01 | 0.00 | 2.76 | 0.010 | ||
| DOI | −0.00 | 0.00 | −0.15 | 0.883 | −0.00 | 0.00 | −0.02 | 0.983 | ||
| CPZeq | 0.00 | 0.00 | −1.33 | 0.194 | −0.00 | 0.00 | −2.03 | 0.051 | ||
| TIV | 0.00 | 0.00 | −0.00 | 0.999 | 0.00 | 0.00 | 0.80 | 0.431 | ||
| LMTV | 0.19 | 0.09 | 2.17 | 0.038 | ||||||
| RMTV | 0.21 | 0.09 | 2.45 | 0.020 | ||||||
| BES | 0.04 | 0.02 | 2.17 | 0.038 | 0.05 | 0.02 | 2.66 | 0.012 | ||
| LMTV*BES | −0.00 | 0.00 | −2.02 | 0.052 | 0.69 | |||||
| RMTV*BES | −0.00 | 0.00 | −2.49 | 0.018 | 0.72 | |||||
FERT-ACC, facial expression recognition task-accuracy; SE, standard error; DOI, durationof illness CPZeq, chlorpromazine equivalent; TIV, total intracranial gyrus volume; LAV, left amygdala volume; RAV, right amygdala volume; BES, basic empathy scale; LFV, left fusiform gyrus volume; RFV, right fusiform gyrus volume; LSTV, left superior temporal gyrus volume; RSTV, right superior temporal gyrus volume; LMTV, left middle temporal gyrus volume; RMTV, right middle temporal gyrus volume.
Regression analysis examining moderation effects between temporal lobe volume and SAT-MC on FERT-ACC in schizophrenia (n = 43)
| Predictor | Left | Right | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| B | SE |
|
| R2 | B | SE |
|
| R2 | |
| Amygdala volume | ||||||||||
| Constant | −1.05 | 0.36 | −2.90 | 0.007 | 0.70 | −0.27 | 0.31 | −0.85 | 0.402 | 0.73 |
| Sex | 0.09 | 0.04 | 2.42 | 0.022 | 0.07 | 0.04 | 1.70 | 0.097 | ||
| Age | −0.01 | 0.00 | −3.31 | 0.002 | −0.01 | 0.00 | −4.23 | 0.000 | ||
| Education | 0.00 | 0.01 | 0.54 | 0.592 | 0.01 | 0.01 | 1.46 | 0.15 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 3.09 | 0.004 | 0.01 | 0.00 | 2.61 | 0.014 | ||
| DOI | −0.00 | 0.00 | −1.26 | 0.215 | −0.00 | 0.00 | −0.99 | 0.325 | ||
| CPZeq | −0.00 | 0.00 | −2.73 | 0.010 | −0.00 | 0.00 | −2.95 | 0.006 | ||
| TIV | 0.00 | 0.00 | 0.32 | 0.748 | 0.00 | 0.00 | 0.54 | 0.593 | ||
| LAV | 1.10 | 0.33 | 3.39 | 0.002 | ||||||
| RAV | 0.13 | 0.19 | 0.69 | 0.497 | ||||||
| SAT-MC | 0.09 | 0.03 | 3.62 | 0.001 | 0.04 | 0.02 | 1.71 | 0.097 | ||
| LAV*SAT-MC | −0.09 | 0.03 | −3.09 | 0.004 | 0.76 | |||||
| RAV*SAT-MC | −0.03 | 0.29 | −1.07 | 0.294 | 0.74 | |||||
| Fusiform gyrus volume | ||||||||||
| Constant | −0.56 | 0.32 | −1.74 | 0.091 | 0.77 | −0.33 | 0.31 | −1.05 | 0.300 | 0.86 |
| Sex | 0.06 | 0.04 | 1.40 | 0.171 | 0.07 | 0.04 | 1.67 | 0.105 | ||
| Age | −0.01 | 0.00 | −3.52 | 0.001 | −0.01 | 0.00 | −4.17 | 0.000 | ||
| Education | 0.01 | 0.01 | 1.32 | 0.196 | 0.01 | 0.01 | 1.39 | 0.176 | ||
| Pre-morbid IQ | 0.00 | 0.00 | 2.480 | 0.018 | 0.01 | 0.00 | 2.62 | 0.014 | ||
| DOI | −0.00 | 0.00 | −1.15 | 0.260 | −0.00 | 0.00 | −0.81 | 0.423 | ||
| CPZeq | −0.00 | 0.00 | −2.66 | 0.012 | −0.00 | 0.00 | −2.96 | 0.006 | ||
| TIV | −0.00 | 0.00 | −0.70 | 0.489 | 0.00 | 0.00 | −0.40 | 0.697 | ||
| LFV | 0.09 | 0.04 | 2.70 | 0.011 | ||||||
| RFV | 0.03 | 0.03 | 1.09 | 0.283 | ||||||
| SAT-MC | 0.08 | 0.03 | 2.83 | 0.008 | 0.05 | 0.02 | 2.29 | 0.029 | ||
| LFV*SAT-MC | −0.01 | 0.00 | −2.23 | 0.033 | 0.81 | |||||
| RFV*SAT-MC | −0.00 | 0.00 | −1.59 | 0.121 | 0.88 | |||||
| Superior temporal gyrus volume | ||||||||||
| Constant | −0.55 | 0.31 | −1.75 | 0.089 | 0.77 | −0.70 | 0.32 | −2.19 | 0.036 | 0.79 |
| Sex | 0.06 | 0.04 | 1.51 | 0.140 | 0.06 | 0.04 | 1.52 | 0.139 | ||
| Age | −0.01 | 0.00 | −3.41 | 0.002 | −0.01 | 0.00 | −3.94 | 0.000 | ||
| Education | 0.01 | 0.01 | 1.31 | 0.200 | 0.00 | 0.01 | 0.42 | 0.680 | ||
| Pre-morbid IQ | 0.00 | 0.00 | 2.40 | 0.022 | 0.00 | 0.00 | 3.41 | 0.001 | ||
| DOI | −0.00 | 0.00 | −0.62 | 0.541 | −0.00 | 0.00 | −1.24 | 0.224 | ||
| CPZeq | −0.00 | 0.00 | −2.57 | 0.015 | −0.00 | 0.00 | −2.38 | 0.024 | ||
| TIV | −0.00 | 0.00 | −0.60 | 0.550 | −0.00 | 0.00 | −0.90 | 0.377 | ||
| LSTV | 0.12 | 0.05 | 2.43 | 0.021 | ||||||
| RSTV | 0.14 | 0.05 | 3.16 | 0.004 | ||||||
| SAT-MC | 0.07 | 0.02 | 3.07 | 0.004 | 0.09 | 0.03 | 3.36 | 0.002 | ||
| LSTV*SAT-MC | −0.01 | 0.00 | −2.41 | 0.022 | 0.81 | |||||
| RSTV*SAT-MC | −0.01 | 0.00 | −2.76 | 0.010 | 0.84 | |||||
| Middle temporal gyrus volume | ||||||||||
| Constant | −0.68 | 0.32 | −2.12 | 0.042 | 0.78 | −0.38 | 0.33 | −1.18 | 0.247 | 0.86 |
| Sex | 0.06 | 0.04 | 1.56 | 0.128 | 0.07 | 0.44 | 1.59 | 0.122 | ||
| Age | −0.01 | 0.00 | −3.42 | 0.002 | −0.01 | 0.00 | −3.37 | 0.002 | ||
| Education | 0.01 | 0.01 | 0.98 | 0.334 | 0.01 | 0.01 | 1.11 | 0.277 | ||
| Pre-morbid IQ | 0.01 | 0.00 | 2.94 | 0.006 | 0.01 | 0.00 | 2.65 | 0.012 | ||
| DOI | −0.00 | 0.00 | −1.15 | 0.260 | −0.00 | 0.00 | −1.11 | 0.275 | ||
| CPZeq | −0.00 | 0.00 | −2.40 | 0.002 | −0.00 | 0.00 | −2.66 | 0.012 | ||
| TIV | −0.00 | 0.00 | −0.40 | 0.689 | 0.00 | 0.00 | 0.17 | 0.865 | ||
| LMTV | 0.06 | 0.02 | 2.83 | 0.008 | ||||||
| RMTV | 0.02 | 0.02 | 1.21 | 0.234 | ||||||
| SAT-MC | 0.09 | 0.03 | 3.32 | 0.002 | 0.05 | 0.03 | 2.18 | 0.036 | ||
| LMTV*SAT-MC | −0.01 | 0.00 | −2.71 | 0.011 | 0.83 | |||||
| RMTV*SAT-MC | −0.00 | 0.00 | −1.53 | 0.135 | 0.88 | |||||
SAT-MC, social attribution task-multiple choice; FERT-ACC, facial expression recognition task-accuracy; SE, standard error; DOI, duration of illness; CPZeq, chlorpromazine equivalent; TIV, total intracranial volume; LAV, left amygdala volume; RAV, right amygdala volume; LFV, left fusiform gyrus volume; RFV, right fusiform gyrus volume; LSTV, left superior temporal gyrus volume; RSTV, right superior temporal gyrus volume; LMTV, left middle temporal gyrus volume; RMTV, right middle temporal gyrus volume.